Citadel Advisors »

Hepion Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Hepion Pharmaceuticals (HEPA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Hepion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Hepion Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hepion Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $20k 29k 0.67

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Hepion Pharmaceuticals

Armistice Capital
Frigate Ventures
Vanguard Group
BlackRock
BlackRock
Geode Capital Management
Citadel Advisors
Renaissance Technologies
State Street Corporation
Susquehanna International
Pnc Financial Services
Tower Research Capital
Morgan Stanley
Federation des caisses Desjardins du Quebec
Advisor Group Holdings

View all funds holding Hepion Pharmaceuticals